COMPARISON OF DOSE ESCALATION OF INFLIXIMAB AND THE ADDITION OF TACROLIMUS IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO INFLIXIMAB AND METHOTREXATE COMBINATION THERAPY

被引：0
|
作者：
Yonemoto, Y. [1 ]
Okamura, K. [1 ]
Kaneko, T. [1 ]
Kobayashi, T. [1 ]
Takagishi, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Dept Orthopaed Surg, Maebashi, Gunma 371, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2097
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：199 / 200
页数：2
相关论文
共 50 条
  • [1] Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab
    Ornetti, P
    Solau, E
    Gaudin, P
    Sibilia, J
    Berthelot, JM
    Puechal, X
    Tavernier, C
    Maillefert, JF
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (09) : 1379 - 1380
  • [2] Increase in methotrexate dose in rheumatoid ahthritis patients with an inadequate response to infliximab
    Ornetti, R
    Solau, E
    Sibilia, J
    Puéchal, X
    Tavernier, C
    Maillefert, J
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 292 - 292
  • [3] Dose escalation of infliximab in rheumatoid arthritis
    Haraoui, B
    Cameron, L
    Ouellet, M
    White, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A6 - A6
  • [4] Alternatives to methotrexate for infliximab combination therapy in rheumatoid arthritis
    Olsen, Nancy
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (09): : 472 - 473
  • [5] The efficacy and safety of abatacept or infliximab in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Becker, J. C.
    Li, T.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II14 - II15
  • [6] Alternatives to methotrexate for infliximab combination therapy in rheumatoid arthritis
    Nancy Olsen
    Nature Clinical Practice Rheumatology, 2006, 2 : 472 - 473
  • [7] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Cohen, Stanley B.
    Kremer, Joel M.
    Dandreo, Kimberly J.
    Reed, George W.
    Magner, Robert
    Shan, Ying
    Kafka, Shelly
    DeHoratius, Raphael J.
    Ellis, Lorie
    Parenti, Dennis
    CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2501 - 2508
  • [8] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Stanley B. Cohen
    Joel M. Kremer
    Kimberly J. Dandreo
    George W. Reed
    Robert Magner
    Ying Shan
    Shelly Kafka
    Raphael J. DeHoratius
    Lorie Ellis
    Dennis Parenti
    Clinical Rheumatology, 2019, 38 : 2501 - 2508
  • [9] THE COMBINATION THERAPY WITH DOSE ESCALATION AND INTERVAL SHORTENING OF INFLIXIMAB MAKES BETTER RESPONSE TO PATIENTS WITH RHEUMATOID ARTHRITIS WHO WERE LOSS OF EFFICACY AGAINST INFLIXIMAB
    Funahashi, K.
    Kojima, T.
    Takahashi, N.
    Kato, D.
    Hattori, Y.
    Hanabayashi, M.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 236 - 237
  • [10] Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis
    Ibáñez, TC
    Tayel, MY
    Criado, AB
    Sanz, AH
    Mola, E
    RHEUMATOLOGY, 2005, 44 (11) : 1467 - 1468
12345